Physician profile
David G Shaw
NPI 1609965235
$2,141.05
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $469 · 2021: $665 · 2022: $438 · 2023: $13.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $760.63 | 2019-2020 | |
| Abbvie INC. | $471.11 | 2019-2023 | Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $210.70 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $123.18 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $122.55 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $110.93 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $83.41 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $52.29 | 2021 | |
| Bio Products Laboratory USA, INC. | $43.44 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $31.72 | 2020-2021 | |
| Grifols USA, LLC | $29.68 | 2021 | |
| Shire North American Group INC | $26.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.99 | 2022 | |
| Amgen INC. | $18.86 | 2020 | |
| Qol Medical, LLC | $17.36 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.